ALNY vs WORX · P/E 76, rev $1.29B vs rev $1.5M
Alnylam Pharmaceuticals Inc (ALNY) versus Scworx Corp (WORX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Scworx Corp (WORX) is a health information services company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported WORX revenue for 2026-06-30 was $1.5M. Net income was -$294.7K. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. WORX currently screens at market cap $1.6M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. WORX currently screens at market cap $1.6M.
Not investment advice. Open the ALNY and WORX stock pages for the full models.
Not investment advice.